Stay updated on Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    - Version updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:37:46.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0; Removed Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T01:07:29.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:18:00.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Added Fallopian tube cancer to the conditions and updated the document revision from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-13T12:33:02.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Primary peritoneal carcinoma was added to the study's conditions. The page revision indicates v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-05T23:38:32.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    The page now shows a revision tag of v3.3.4, replacing the previous v3.3.3 tag. This is a minor maintenance update and does not alter study details or navigation.
    Difference
    0.0%
    Check dated 2026-01-15T10:38:29.000Z thumbnail image

Stay in the know with updates to Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial page.